Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
41
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A Novel c-kit Positive Biphenotypic Acute Leukemia Cell Line, TMBL-1, Carrying a p53 Point Mutation

Shinsuke Suzuki Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Kimiharu Uozumi Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Shuichi Hanada National Hospital, Kyushu Cardiovascular Center, Kagoshima, Japan
,
Xiao-Yan Lin Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Nobuhito Ohno Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Yoshifusa Takatsuka Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Syogo Takeuchi Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Satsuki Owatari Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
,
Taketsugu Takeshita National Hospital, Kyushu Cardiovascular Center, Kagoshima, Japan
&
Terukatsu Arima Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
 show all
Pages 849-857 | Published online: 01 Jul 2009

  • Drexler, H.G., Thiel, E. and Ludwig, W.D. (1991) "Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia", Leukemia 5, 637-645. Review.
  • Matutes, E., Morilla, R., Farahat, N., Carbonell, K. Swansbury, J., Dyer, M. and Catovsky, D. (1997) "Definition of acute biphenotypic leukemia", Haematologica 82, 64-66.
  • Killick, S., Matutes, E., Powles, R.L., Hamblin, M., Swansbury, J., Treleaven, J.G., Zomas, A., Atra, A. and Catovsky, D. (1999) "Outcome of biphenotypic acute leukemia", Haematologica 84, 699-706.
  • Carbonell, F., Swansbury, J., Min, T., Matutes, E., Farahat, N., Buccheri, V., Morilla, R., Seeker-Walker, L. and Catovsky, D. (1996) "Cytogenetic findings in acute biphenotypic leukemia", Leukemia 10, 1283-1287.
  • Nosaka, T., Ohno, H., Doi, S., Fukuhara, S., Miwa, H., Kita, K., Shirakawa, S., Honjo, T. and Hatanaka, M. (1988) "Phenotypic conversion of T lymphoblastic lymphoma to acute biphenotypic leukemia composed of lymphoblasts and myeloblasts. Molecular genetic evidence of the same clonal origin", J. Clin. Investig. 81, 1824-1828.
  • Ohyashiki, K., Ohyashiki, J.H. and Sandberg, A.A. (1986) "Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells", Cancer Res. 46, 3642-3647.
  • Mallet, M.K., Mane, S.M., Meltzer, S.J. and Needleman, S.W. (1989) "c-myc amplification coexistent with activating N-ras point mutation in the biphenotypic leukemic cell line RED-3", Leukemia 3, 511-515.
  • Cohen, A., Grunberger, T. Vanek, W., Dube, I.D., Doherty, P.J., Letarte, M., Roifman, C. and Freedman, M.H. (1991) "Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell line", Blood 78, 94-102.
  • Tanabe, S., Fukuhara, S., Yoneda, T., Ohmori, K., Nosaka, T., Hatanaka, M. and Okuma, M. (1993) "Characterization of a novel biphenotypic leukemia cell line. TA-1, with myeloperoxidase and inducible cytoplasmic mu chain: altered rearrangement patterns of antigen receptor genes", Int. J. Hematol. 57, 229-243.
  • Pocock, C.F., Malone, M., Booth, M., Evans, M., Morgan, G., Greil, J. and Cotter, F.E. (1995) "BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation", Br. J. Haematol. 90, 855-867.
  • Kees, U.R., Campbell, L.J., Ford, J., Willoughby, M.I.,. Peroni, S.E., Ranford, P.R. and Garson, O.M. (1995) "New translation t(2:13)(p12:q34) and rearrangement of the MLL gene in a childhood leukemia cell line", Genes Chromosomes Cancer 12, 201-208.
  • Saito, M., Kumagai, M., Okazaki, T., Nakazawa, S., Shapiro, L.H., Look, A.T. and Campana, D. (1995) "Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells", Leukemia 9, 1508-1516.
  • Zinzar, S., Silverman, L.K., Richardson, E.B., Bekesi, G. and Holland, J.F. (1998) "Azacytidine plus verapamil induces the differentiation of a newly characterized hiphenotypic human myeloid-B lymphoid leukemic cell line BW-90", Leuk. Res. 22, 677-685.
  • Inokuchi, K., Shinohara, T., Futaki, M., Hanawa, H., Tanosaki, S., Yamaguchi, H., Nomura, T. and Dan, K. (1998) "Establishment of a cell line with variant BCR/ABl, breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia", Genes Chromosomes Cancer 23, 227-238.
  • Matsuo, Y., Ariyasu, T., Ohmoto, E., Kimura, I. and Minowada, J. (1991) "Bi-phenotypic t(9:22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset: and NALM-21, NALM-22 and NALM-23, established after relapse", Hum. Cell 4, 335-338.
  • Ariyasu, T., Matsuo, Y., Harashima, A., Nakamura, S., Takaba, S., Tsubota, T. and Orita, K. (1998) "Establishment and characterization of biphenotypic acute leukemia cell lines with a variant Ph translocation t(9;22: 10) (q34;q11:q22)", Hum. Cell 11, 43-50.
  • Matsuo, Y., Sugimoto, A., Harashima, A., Nishizaki, C., Drexler, H G. and Orita, K. (1998) "Myeloperoxidase positive acute lymphoblastic leukemia cell lines. NALM-30, NALM-31 and NALM-32. carrying Philadelphia chromosome with biphenotypic characteristics", Hum. Cell 11, 221-230.
  • Matsuo, Y., Drexler, H.G., Takeuchi, M. and Orita, K. (1999) "A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9:22)(q34;q11) established from a patient with acute leukemia", Leak. Res. 23, 731-740.
  • Ashman, L.K., Cambareri, A.C., To, L.B., Levinsky, R.J. and Jurtner, C.A. (1991) "Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow", Blood 78, 30-37.
  • de Castro, C.M., Denning, S.M., Langdon, S., Vaudenbark, G.R., Kurtzberg, J., Scearce, R., Haynes, B.F. and Kaufman, R.E. (1994) "The c-kit proto-oncogene receptor is expressed on a subset of human CD3 -, CD4 -, CD8 - (triple negative) thymocytes", Exp. Hematol. 22, 1025-1033.
  • Knapp, W., Strobl, H. and Majdic, O. (1994) "Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis", Cytometry 18, 187-198.
  • Bene, M.C., Bemier, M., Casasnovas, R.O., Castoldi, G., Knapp, W., Lanza, F., Ludwig, W.D., Matutes, E., Orfao, A., Sperling, C. and van't Veer, M.B. (1998) "The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL)", Blood 92, 596-599.
  • Hu, Z.B., Ma, W., Uphoff, C.C., Quentmeier, H. and Drexler, H.G. (1994) "C-kit expression in human megakaryoblastic leukemia cell lines", Blood 83, 2133-2144.
  • Monta, S., Tsuchiya, S., Fujie, H., Itano, M., Ohashi, Y., Minegishi, M., Imaizumi, M., Endo, M., Takano, N. and Konno, T. (1996) "Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservalion of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture", Leukemia 10, 102-105.
  • McNiece, I.K., Langley, K.E. and Zsebo, K.M. (1991) "The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7", J. Immunol. 146, 3785-3790.
  • Morrissey, P.J., McKenna, H., Widmer, M.B., Braddy, S., Voice, R., Charrier, K., Williams, D.E. and Watson, J.D. (1994) "Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3¯CD4¯/CD8¯ thymocytes: synergy with IL-7", Cell Immunol. 157, 118-131.
  • Kondo, M., Weissman, I.L. and Akashi, K. (1997) "ldentification of clonogenic common lymphoid progenitors in mouse bone marrow", Cell 91, 661-672.
  • Smith, S.D., Morgan, R., Link, M.P., McFall, P. and Hecht, F. (1986) "Cytogenetic and immunophenotypic analysis of cell lines of cell lines established from patients with T cell leukemia/lymphoma", Blood 67, 650-656.
  • ISCN (1995) In: Mitelman, R. ed. An International System for Human Cytogenetic Nomenclature (S. Karger, Basel).
  • Mosmann, T. (1983) "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxity assays", J. Immunol. Methods 65, 55-63.
  • Orita, M., Suzuki, Y., Sckiya, T. and Hayashi, K. (1989) "Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction", Genomics 5, 874-879.
  • Rader, A.E., Avery, A., Wait, C.L., McGreevey, L.S., Faigel, D. and Heinrich, M.C. (2001) "Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit", Cancer 25, 269-275.
  • Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) "p53 mutations in human cancers", Science 253, 49-53.
  • Hara, J., Benedict, S.H., Champagne, E., Takihara, Y., Mak, T.W., Minden, M. and Gelfand, E.W. (1988) "T cell receptor delta gene rearrangements in acute lymphoblastic leukemia", J. Clin. Investig. 82, 1974-1982.
  • Hershfield, M.S., Kurtzberg, J., Harden, E., Moore, J.O., Whang-Peng, J. and Haynes, B.F. (1984) "Conversion of a stem cell leukemia from a T-Iymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin", Proc. Natl Acad. Sci. USA 81, 253-257.
  • Kurtzberg, J., Bigner, S.H. and Hershfield, M.S. (1985) "Establishment of the DU.528 human lymphohemopoietic stem cell line", J. Exp. Med. 162, 1561-1578.
  • Kurtzberg, J., Waldmann, T.A., Davey, M.P., Bigner, S.H., Moore, J.O., Hershfield, M.S and Haynes, B.F. (1989) "CD?+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells", Blood 73, 381-390.
  • Nishii, K., Kita, K., Miwa, H., Kawakami, K., Nakase, K., Masuya, M., Morita, N., Omay, S.B., Otsuji, N., Fukumoto, M. and Shirakawa, S. (1992) "C-kit gene expression in CD7 positive acute Iymphoblastic leukemia: close correlation with expression of myeloid-associated antigens", Leukemia 6, 662-668.
  • Caceres-Cones, J.R., Alvarado-Moreno, J.A., Waga, K., Rangel-Corona. R., Monroy-Garcia, A., Rocha-Zavaleta, L., Urdiales-Ramos, J., Weiss-Steider, B., Haman, A., Hugo, P., Brousseau, R. and Hoang, T. (2001) "Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias", Cancer Res. 61, 6281-6289.
  • Ashman, L.K., Ferrao, P., Cole, S.R. and Cambareri, A.C. (1999) "Effects of mutant c-kit in early myeloid cells", Leuk. Lymphoma 34, 451-461.
  • Beghini, A., Peterlongo, P. and Ripamonti, C.B. (2002) "c-kit mutations in core binding factor Ieukemias [letter]", Blood 95, 726-727.
  • Leslie, N.R., O'Prey, J., Bartholomew, C. and Harrison, P.R. (1998) "An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin", Blood 92, 4798-4807.
  • Kitayama, H., Kanakura, Y. and Furitsu, T. (1995) "Constitutively activating mutations of c-kit receptor lyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines", Blood 85, 790-798.
  • Rubin, B.P., Singer, S., Tsao, C., Duensing, A., Lux, M.L., Ruiz, R., Hibbard, M.K., Chen, C.J., Xiao, S., Tuveson, D.A., Demetri, G.D., Fletcher, C.D. and Fletcher, J.A. (2001) "KIT activation is a ubiquitous feature of gastrointestinal stromal tumors", Cancer Res. 61, 8118-8121.
  • van Oosterom, A.T., Judson, I., Verweij, J., Stroobants, S., Donato di Paola, E., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., Silberman, S. and Nielsen, O.S. (2001) "Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumors: a phase I study", Lancet 358, 1421-1423.
  • Imamura, J., Miyoshi, I. and Koeffer, H.P. (1994) "p53 in haematologic malignancies", Blood 84, 2412-2421.
  • Harris, C.C. (1996) "Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies", J. Natl Cancer Inst. 88, 1442-1455.
  • Lam, V., McPherson, J.P., Salmena, L., Lees, J., Chu, W., Sexsmith, E., Hedley, D.W., Freedman, M.H., Reed, J.C., Malkin, D. and Goldenberg, G.J. (1999) "p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin", Leuk. Res. 23, 871-880.
  • Wahl, A.F., Donaldson, K.L., Fairchild, C., Lee, F.Y., Foster, S.A., Demers, G.W. and Galloway, D.A. (1996) "Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis", Nat. Med. 2, 72-79.
  • Cho, Y. Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) "Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations", Science 265, 346-355.
  • Bykov, V.J., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K.G. and Selivanova, G. (2002) "Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound", Nat. Med. 8, 282-288.
  • Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., Kamada, N., Kobayashi, Y., Takemoto, Y. Kitani, T., Toyama, K., Ohtake, S., Yazaki, Y., Ueda, R. and Hirai, H. (1996) "Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle. MTSI/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies", Blood 87, 4949-4958.
  • Wada, M., Bartram, C.R., Nakamura, H., Hachiya, M., Chen, D.L., Borenstein, J., Miller, C.W., Ludwig, L., Hansen-Hagge, T.K. and Ludwig, W.D. (1993) "Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood", Blood 82, 3163-3169.
  • Diccianni, M.B., Yu, J., Hsiao, M., Mukherjee, S., Shao, L.E. and Yu, A.L. (1994) "Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia", Blood 84, 3105-3112.
  • Drexler, H.G. and Matsuo, Y. (1999) "Guidelines for the characterization and publication of human malignant hematopoietic cell lines", Leukemia 13, 835-842.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.